ARTV — Artiva Biotherapeutics Share News
0.000.00%
Last trade - 00:00- $300.67m
- -$48.72m
Artiva Biotherapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Artiva Biotherapeutics Inc expected to post a loss of 62 cents a share - Earnings Preview
Brief: Artiva Biotherapeutics Inc Thad Huston To Separate As CFO Effective May 22, 2026
U.S. STOCKS ON THE MOVE-Corning, BILL Holdings, Moderna
U.S. STOCKS ON THE MOVE-Corning, Moderna, News Corp
U.S. STOCKS ON THE MOVE-Coinbase, Microchip, Wendy's
U.S. STOCKS ON THE MOVE-Cloudflare, IREN, Monster Beverage
Brief: Artiva Biotherapeutics Announces Pricing Of $300 Million Underwritten Offering Of Common Stock And Pre-Funded Warrants
Artiva jumps as cell therapy shows benefits in rheumatoid arthritis
Brief: Artiva Announces Positive Initial Clinical Data With Allonk® Across Multiple Autoimmune Diseases And FDA Alignment To Initiate Phase 3 Registrational Trial In Rheumatoid Arthritis In 2026
Brief: Artiva Biotherapeutics Announces Appointment Of Thad Huston As CFO
U.S. STOCKS ON THE MOVE-TransDigm, Citigroup, Cisco Systems
U.S. STOCKS ON THE MOVE-Floor & Decor, Starbucks, gold miners
Artiva rises after positive safety data for new autoimmune disease therapy
U.S. STOCKS ON THE MOVE-ExxonMobil, Yatra, Venture Global
Artiva rises after positive early data for new autoimmune disease therapy
Artiva surges on US FDA's 'fast track' tag for rheumatoid arthritis therapy
U.S. STOCKS ON THE MOVE-Oracle, American Express, Magna International
U.S. STOCKS ON THE MOVE-Revolution Medicines, Artiva, Jefferies